Your fact-checks will appear here
The use of chromium picolinate for improving HbA1c levels in type 2 diabetes patients, with varying doses and formulations.
has been studied in randomized trials and meta-analyses and produces a small, inconsistent reduction in body weight—typically on the order of about 0.5–1.1 kg over weeks to months—which most reviewers...
Randomized trials and meta-analyses point most consistently to chromium picolinate as the formulation with the strongest signal for modest HbA1c improvements in type 2 diabetes, typically at supplemen...